LEN vs NVR vs PHM
161 measures in 16 categories, one definition each, computed from filings and market data.
LEN39.8
Lennar Corporation
Consumer Cyclical · Residential Construction
$77.08 −0.79%$18.3B mkt cap
Score DNA
NVR48.1
NVR, Inc.
Consumer Cyclical · Residential Construction
$5,919.82 −0.36%$15.9B mkt cap
Score DNA
PHM48.0
PulteGroup, Inc.
Consumer Cyclical · Residential Construction
$113.55 +0.50%$21.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
LEN NVR PHM · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Insider open-market buys, 180d | 45 | 2 | 0 |
| Insider $ bought, 180d | $595.29M | $0.48M | — |
| Congress purchases, 180d | 2 | 2 | 1 |
| Last Congress purchase | 2026-08-10 | 2026-09-11 | 2026-09-11 |
| 13F net change in holders | +1 | +33 | +10 |
| ETFs adding shares, 30d | 768 | 554 | 1,060 |
| ETFs trimming, 30d | 762 | 550 | 952 |
| Net ETF funds, 30d | +6 | +4 | +108 |
Valuation
16 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| P/E (TTM) | 14.0x
61st
|
13.9x
56th
|
11.3x
22nd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | — |
| Price / sales | 0.6x
26th
|
1.7x
89th
|
1.3x
68th
|
| Price / book | 0.9x
37th
|
4.7x
95th
|
1.7x
74th
|
| Price / tangible book | 1.1x
39th
|
5.8x
100th
|
2.1x
83rd
|
| Price / free cash flow | 20.2x
71st
|
15.2x
41st
|
14.3x
35th
|
| Price / operating cash flow | 17.6x
67th
|
14.9x
56th
|
13.3x
39th
|
| Enterprise value | $21.5B
84th
|
$15.7B
79th
|
$22.0B
95th
|
| EV / sales | 0.7x
11th
|
1.7x
89th
|
1.3x
68th
|
| EV / EBITDA | 10.7x
50th
|
10.3x
44th
|
9.1x
28th
|
| EV / EBIT | 11.3x
50th
|
10.5x
33rd
|
9.5x
17th
|
| EV / free cash flow | 23.7x
71st
|
15.0x
35th
|
14.6x
29th
|
| Earnings yield | 7.2%
42nd
|
7.2%
47th
|
8.8%
79th
|
| FCF yield | 5.0%
37th
|
6.6%
63rd
|
7.0%
68th
|
| Operating cash flow yield | 5.7%
37th
|
6.7%
47th
|
7.5%
63rd
|
| Graham number (per share) | $106.09
61st
|
$3,249.28
100th
|
$121.88
72nd
|
Profitability (TTM)
12 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Gross margin | 9.5%
0th
|
22.2%
47th
|
24.5%
68th
|
| EBITDA margin | 6.3%
37th
|
16.1%
84th
|
14.8%
74th
|
| Operating margin | 5.3%
26th
|
14.9%
79th
|
14.6%
74th
|
| EBIT margin | 5.9%
37th
|
15.9%
89th
|
14.1%
79th
|
| Net margin | 4.1%
32nd
|
12.1%
89th
|
11.6%
84th
|
| NOPAT margin | 4.0%
21st
|
11.5%
79th
|
11.2%
74th
|
| FCF margin | 2.8%
26th
|
11.1%
95th
|
9.2%
68th
|
| Operating cash flow margin | 3.3%
26th
|
11.3%
89th
|
9.9%
68th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 4.1%
0th
|
7.3%
16th
|
7.1%
11th
|
| Stock comp / revenue | 0.4%
56th
|
0.7%
89th
|
0.4%
33rd
|
| Effective tax rate | 25.8%
89th
|
23.0%
47th
|
23.6%
58th
|
Returns on capital
11 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| ROE (on average equity) | 5.9%
32nd
|
31.5%
95th
|
14.9%
79th
|
| ROA | 3.8%
32nd
|
20.0%
100th
|
10.6%
79th
|
| ROIC | 5.1%
26th
|
33.3%
100th
|
13.6%
63rd
|
| ROCE | 6.0%
37th
|
33.6%
100th
|
15.1%
74th
|
| Return on tangible assets | 5.6%
37th
|
26.2%
100th
|
12.9%
79th
|
| Cash ROIC (OCF / invested capital) | 4.2%
32nd
|
32.9%
95th
|
12.1%
74th
|
| Gross profitability (GP / assets) | 9.1%
11th
|
38.3%
95th
|
22.0%
63rd
|
| ROIC, 3-yr average | 7.4%
21st
|
31.0%
100th
|
16.1%
68th
|
| ROIC, 5-yr average | 11.5%
21st
|
38.3%
95th
|
22.7%
79th
|
| ROE, 5-yr average | 13.6%
16th
|
40.5%
100th
|
23.8%
74th
|
| Incremental ROIC | 30.5%
68th
|
20.5%
63rd
|
-42.9%
26th
|
Growth
17 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Revenue growth (TTM YoY) | -8.1%
53rd
|
-10.6%
26th
|
-7.3%
63rd
|
| Revenue growth (QoQ) | 1.3%
0th
|
23.7%
79th
|
16.9%
53rd
|
| Revenue CAGR, 3 yr | -1.5%
32nd
|
-2.0%
26th
|
-0.8%
47th
|
| Revenue CAGR, 5 yr | 4.6%
53rd
|
1.7%
37th
|
6.0%
74th
|
| Gross profit CAGR, 3 yr | -27.5%
0th
|
-6.9%
42nd
|
-6.9%
47th
|
| Operating income CAGR, 3 yr | -31.7%
17th
|
-10.1%
61st
|
-12.7%
56th
|
| Net income growth (TTM YoY) | -51.1%
28th
|
-24.9%
61st
|
-30.5%
56th
|
| Net income CAGR, 3 yr | -30.5%
17th
|
-10.9%
72nd
|
-11.6%
67th
|
| EPS growth (TTM YoY) | -47.5%
28th
|
-18.5%
67th
|
-28.0%
56th
|
| EPS CAGR, 3 yr | -26.3%
17th
|
-5.1%
78th
|
-7.4%
67th
|
| EPS CAGR, 5 yr | -16.3%
17th
|
6.5%
61st
|
9.2%
67th
|
| FCF growth (TTM YoY) | — | -13.4%
31st
|
14.8%
38th
|
| FCF CAGR, 3 yr | -44.2%
20th
|
-15.7%
73rd
|
-7.7%
87th
|
| Operating cash flow CAGR, 3 yr | -41.9%
25th
|
-15.5%
69th
|
-6.9%
88th
|
| Book value CAGR, 3 yr | -0.0%
5th
|
-0.5%
0th
|
15.6%
79th
|
| Dividend CAGR, 3 yr | 3.5%
33rd
|
— | 7.9%
83rd
|
| Sustainable growth rate | 3.7%
17th
|
31.5%
100th
|
13.4%
78th
|
Margin history & stability
7 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Gross margin, 3-yr average | 17.5%
11th
|
24.0%
58th
|
27.3%
84th
|
| Operating margin, 3-yr average | 9.9%
47th
|
17.2%
84th
|
18.6%
89th
|
| Net margin, 3-yr average | 7.8%
42nd
|
14.3%
84th
|
14.6%
89th
|
| FCF margin, 3-yr average | 3.8%
32nd
|
12.6%
100th
|
8.1%
74th
|
| Revenue stability (0-1) | 0.42
32nd
|
0.32
26th
|
0.61
58th
|
| Earnings stability (0-1) | 0.70
84th
|
0.00
0th
|
0.09
26th
|
| Margin stability (0-1) | 0.68
0th
|
0.93
89th
|
0.92
74th
|
Liquidity (latest quarter)
7 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Cash & short-term investments | $1.2B
79th
|
$1.2B
89th
|
$1.9B
95th
|
| Net cash (− = net debt) | −$3.1B
5th
|
$146.6M
89th
|
−$412.8M
63rd
|
| Working capital | $13.3B
89th
|
$2.5B
53rd
|
$12.7B
84th
|
| Current ratio | 8.38
74th
|
3.38
32nd
|
5.27
53rd
|
| Quick ratio | 1.17
47th
|
1.21
58th
|
0.65
32nd
|
| Cash ratio (cash + ST investments / current liabilities) | 0.64
58th
|
1.16
84th
|
0.63
53rd
|
| Defensive interval (days) | 568 days
74th
|
659 days
84th
|
427 days
53rd
|
Leverage & solvency (latest quarter)
13 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Total debt | $4.3B
89th
|
$1.1B
42nd
|
$2.3B
79th
|
| Debt / equity | 0.20
26th
|
0.31
42nd
|
0.18
21st
|
| Net debt / equity | 0.15
37th
|
−0.04
16th
|
0.03
21st
|
| Debt / assets | 12.9%
26th
|
19.2%
42nd
|
12.6%
21st
|
| Debt / capital | 16.6%
26th
|
23.7%
42nd
|
15.0%
21st
|
| Debt / EBITDA | 2.14
56th
|
0.69
17th
|
0.95
28th
|
| Net debt / EBITDA | 1.57
56th
|
−0.10
17th
|
0.17
22nd
|
| Interest coverage (EBIT / interest) | 16.6x
33rd
|
2,889.8x
92nd
|
4,619.9x
100th
|
| Cash interest coverage | 9.1x
33rd
|
2,063.0x
92nd
|
3,245.5x
100th
|
| Debt payback (years of OCF) | 4.1 yrs
47th
|
1.0 yrs
18th
|
1.4 yrs
24th
|
| Liabilities / assets | 35.0%
42nd
|
38.0%
53rd
|
28.7%
21st
|
| IS credit model rating | AA | AAA | AAA |
| Implied credit spread (bps) | 80
32nd
|
50
0th
|
50
0th
|
Efficiency
11 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Asset turnover | 0.94
58th
|
1.65
100th
|
0.92
53rd
|
| Fixed asset turnover | — | 39.21
53rd
|
— |
| Inventory turnover | 2.2
74th
|
3.3
84th
|
0.9
37th
|
| Receivables turnover | 25.8
35th
|
206.8
94th
|
— |
| Days sales outstanding | 14 days
63rd
|
2 days
16th
|
0 days
0th
|
| Days inventory outstanding | 168 days
21st
|
110 days
16th
|
397 days
63rd
|
| Days payables outstanding | 21 days
42nd
|
21 days
58th
|
21 days
53rd
|
| Cash conversion cycle (days) | 161 days
26th
|
90 days
16th
|
375 days
63rd
|
| Capex / revenue | 0.4%
26th
|
0.2%
16th
|
0.7%
53rd
|
| Capex / depreciation | 1.29
58th
|
0.77
32nd
|
1.01
42nd
|
| Operating expense ratio | 10.8%
32nd
|
7.6%
0th
|
9.6%
11th
|
Cash flow & earnings quality
7 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Operating cash flow / net income | 0.79
33rd
|
0.93
50th
|
0.85
44th
|
| FCF / net income | 0.69
33rd
|
0.92
61st
|
0.79
50th
|
| FCF / operating cash flow | 87.1%
29th
|
98.1%
88th
|
93.0%
65th
|
| Capex / operating cash flow | 12.9%
65th
|
1.9%
12th
|
7.0%
35th
|
| Accruals ratio | 0.8%
53rd
|
1.3%
68th
|
1.6%
74th
|
| Sloan accruals ratio | -0.2%
53rd
|
-31.6%
5th
|
-0.4%
47th
|
| Earnings quality score (0-1) | 0.50
22nd
|
0.75
44th
|
0.75
44th
|
Scores & forensic checks
15 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| IS score | 40
42nd
|
48
74th
|
48
68th
|
| IS profitability | 20
32nd
|
62
95th
|
45
79th
|
| IS growth | 14
37th
|
16
47th
|
16
53rd
|
| IS value | 79
58th
|
53
21st
|
79
47th
|
| IS momentum | 36
32nd
|
39
53rd
|
38
47th
|
| IS risk (safety) | 90
37th
|
100
53rd
|
100
53rd
|
| IS quality | 56
42nd
|
67
74th
|
61
63rd
|
| IS balance sheet | 71
37th
|
95
95th
|
86
79th
|
| IS earnings quality | 83
47th
|
88
79th
|
86
68th
|
| IS cash flow | 42
32nd
|
57
58th
|
58
63rd
|
| Piotroski F-score (0-9) | 5
58th
|
3
0th
|
3
0th
|
| Altman Z-score | 3.6
42nd
|
13.1
100th
|
5.9
74th
|
| Beneish M-score | −2.79
16th
|
−1.13
89th
|
−2.33
58th
|
| Ohlson O-score | −9.71
47th
|
−10.13
21st
|
−10.90
11th
|
| IS credit score | 86
47th
|
96
79th
|
96
79th
|
Size (TTM)
8 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| Market cap | $18.3B
84th
|
$15.9B
79th
|
$21.6B
95th
|
| Revenue | $32.0B
89th
|
$9.4B
74th
|
$16.4B
84th
|
| EBITDA | $2.0B
84th
|
$1.5B
74th
|
$2.4B
95th
|
| Net income | $1.3B
84th
|
$1.1B
74th
|
$1.9B
95th
|
| Free cash flow | $908.2M
74th
|
$1.0B
84th
|
$1.5B
95th
|
| Total assets | $33.4B
89th
|
$5.5B
63rd
|
$18.3B
84th
|
| Shareholders' equity | $21.6B
89th
|
$3.4B
63rd
|
$13.0B
84th
|
| Employees | 12,532
89th
|
6,300
63rd
|
6,506
68th
|
Price performance
9 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| 1 day | −0.8% | −0.4% | +0.5% |
| 1 week | +0.5% | +0.3% | +1.3% |
| 1 month | −2.7% | −5.2% | −4.5% |
| 3 months | −6.4% | −8.2% | −7.6% |
| 6 months | −15.4% | −15.4% | −9.9% |
| Year to date | −24.4% | −18.7% | −4.0% |
| 1 year | −35.6% | −22.6% | −8.2% |
| 3 years, cumulative | −29.0% | −4.2% | +53.8% |
| 5 years, cumulative | −10.6% | +22.4% | +151.6% |
Technicals
4 measures| Measure | LEN | NVR | PHM |
|---|---|---|---|
| RSI 14 | 46.6 | 43.7 | 43.9 |
| From 52-week high | −41.1% | −27.8% | −20.9% |
| From 52-week low | +7.4% | +7.6% | +6.0% |
| Beta | 1.38 | 0.90 | 1.16 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17